Evidence map›Paper›PMID 27417770›Full record

ArticleHealthcare (Basel, Switzerland)2015

Obesity and Insulin Resistance Are the Central Issues in Prevention of and Care for Comorbidities.

Elisabeth Govers

Registry-linked trialAbstract read
In one paragraph

Article in Healthcare (Basel, Switzerland), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05810883 (Prevalence and Risk Factors of Insulin Resistance in Overweight and Obese Adolescents), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05810883 unknown statusnot on this mapstarted 2023, after this paper: background citation

Prevalence and Risk Factors of Insulin Resistance in Overweight and Obese Adolescents

TypeobservationalSponsorAssiut UniversityRan2023 to 2025Enrolled50ConditionsInsulin ResistanceArmsBlood Tests, Serum Fasting Insulin and Glucose
3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Elisabeth GoversAmstelring Foundation for Primary Care, The Dutch Dietitians Knowledge Centre for Overweight and Obesity (KDOO), Amsterdam 1065AC, The Netherlands. e.govers112@upcmail.nl.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

For a long time the assumption has been that, although weight reduction was necessary and desirable, comorbidities were far more important and needed treatment even if weight loss was not a treatment goal, preferably with medication. This controversy leads to postponement of treatment, and later on causes very intensive medical treatment, thus, raising the health care costs to unacceptable levels, leading to the medicalization of individuals, and a declining of the responsibility of patients for their health, leaving the question of when to regard their own weight as a problem that should be dealt with up to individuals. The central problem is insulin resistance, which leads to a cascade of health problems. This condition should be diagnosed in primary practice and obesity clinics to ensure a better, tailor-made treatment for patients. Treatment should start at the earliest stage possible, when comorbidities are still reversible and includes a personalized dietary advice and counseling, preferably by a dietitian, to tackle insulin resistance. An exercise program is part of the treatment.

Indexed as

comorbiditiesdietitianinsulin resistancemetabolic syndromeobesitytreatment

Identifiers

PMID27417770
PMCPMC4939529

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.